Filing Details

Accession Number:
0001209191-15-022909
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-05 16:05:35
Reporting Period:
2015-03-03
Filing Date:
2015-03-05
Accepted Time:
2015-03-05 16:05:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585005 J. Steven Kafka 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-03 20,656 $4.16 25,336 No 4 M Direct
Common Stock Disposition 2015-03-03 20,656 $47.68 4,680 No 4 S Direct
Common Stock Acquisiton 2015-03-03 3,124 $4.16 7,804 No 4 M Direct
Common Stock Disposition 2015-03-03 3,124 $47.69 4,680 No 4 S Direct
Common Stock Acquisiton 2015-03-03 9,344 $7.12 14,024 No 4 M Direct
Common Stock Disposition 2015-03-03 9,344 $47.57 4,680 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-03-03 20,656 $0.00 20,656 $4.16
Common Stock Stock Option (right to buy) Disposition 2015-03-03 3,124 $0.00 3,124 $4.16
Common Stock Stock Opiton (right to buy) Disposition 2015-03-03 9,344 $0.00 9,344 $7.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,674 2023-03-07 No 4 M Direct
6,248 2023-03-07 No 4 M Direct
35,156 2023-05-22 No 4 M Direct
Footnotes
  1. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.50 to $47.92, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  2. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.60 to $47.75, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  3. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.51 to $47.61, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  4. This option is a non-qualified portion of an option granted on March 7, 2013 that vested 25% on January 2, 2014 and then vests in equal quarterly installments until fully vested on January 2, 2017.
  5. This option is a non-qualified portion of an option granted on March 7, 2013 that vests in equal quarterly installments beginning on June 7, 2013 until fully vested on March 7, 2017.
  6. This option was granted on May 22, 2013 and vests in equal quarterly installments beginning on August 22, 2013 until fully vested on May 22, 2017.